Dr. Kirmse is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2500 N State St
Suite 4800
Jackson, MS 39216Phone+1 601-984-1900
Education & Training
- Icahn School of Medicine at Mount SinaiFellowship, Clinical Biochemical Genetics, 2007 - 2009
- Icahn School of Medicine at Mount SinaiResidency, Pediatrics/Medical Genetics and Genomics, 2005 - 2007
- University of FloridaResidency, Pediatrics, 2002 - 2004
- Louisiana State University School of MedicineInternship, Transitional Year, 2001 - 2002
- University of Miami Leonard M. Miller School of MedicineClass of 2001
Certifications & Licensure
- AR State Medical License 2022 - 2026
- WV State Medical License 2024 - 2026
- CA State Medical License 2022 - 2026
- WA State Medical License 2021 - 2026
- NH State Medical License 2024 - 2026
- MD State Medical License 2010 - 2026
- RI State Medical License 2024 - 2026
- American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsA recurrent missense variant in SLC9A7 causes nonsyndromic X-linked intellectual disability with alteration of Golgi acidification and aberrant glycosylation.Wujood Khayat, Anna Hackett, Marie Shaw, Alina Ilie, Tracy Dudding-Byth
Human Molecular Genetics. 2019-02-15 - 48 citationsHIV protease inhibitors inhibit the development of preerythrocytic-stage plasmodium parasites.Charlotte V. Hobbs, Tatiana Voza, Alida Coppi, Brian Kirmse, Kennan C. Marsh
The Journal of Infectious Diseases. 2009-01-01 - 11 citationsMalaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P...Charlotte V. Hobbs, Erin E. Gabriel, Portia Kamthunzi, Gerald Tegha, Jean Tauzie
Plos One. 2016-12-09
Press Mentions
- Amber Olsen Is Racing Against Time to Fund a Gene Therapy That Might Save Her Dying 5-Year-Old from a Rare Genetic DiseaseOctober 26th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: